Group One Trading’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Hold |
0
| – | – | – | 3501 |
|
2025
Q1 | – | Hold |
0
| – | – | – | 3400 |
|
2024
Q4 | – | Hold |
0
| – | – | – | 3270 |
|
2024
Q3 | – | Hold |
0
| – | – | – | 2924 |
|
2024
Q2 | – | Hold |
0
| – | – | – | 2973 |
|
2024
Q1 | – | Sell |
-186,355
| Closed | -$198K | – | 3061 |
|
2023
Q4 | $198K | Buy |
+186,355
| New | +$198K | ﹤0.01% | 743 |
|
2023
Q3 | – | Hold |
0
| – | – | – | 3179 |
|
2023
Q2 | – | Hold |
0
| – | – | – | 3133 |
|
2023
Q1 | – | Hold |
0
| – | – | – | 3046 |
|
2022
Q4 | – | Hold |
0
| – | – | – | 3094 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 3078 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 3119 |
|
2022
Q1 | – | Sell |
-5,578
| Closed | -$31K | – | 3111 |
|
2021
Q4 | $31K | Buy |
5,578
+5,528
| +11,056% | +$30.7K | ﹤0.01% | 1693 |
|
2021
Q3 | $0 | Buy |
+50
| New | – | ﹤0.01% | 3062 |
|
2021
Q2 | – | Sell |
-27,237
| Closed | -$233K | – | 2947 |
|
2021
Q1 | $233K | Buy |
27,237
+27,235
| +1,361,750% | +$233K | ﹤0.01% | 985 |
|
2020
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 2478 |
|
2020
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 2359 |
|
2020
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 2182 |
|
2020
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 2093 |
|
2019
Q4 | $0 | Sell |
2
-1
| -33% | – | ﹤0.01% | 2077 |
|
2019
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 2036 |
|
2019
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 1966 |
|
2019
Q1 | $0 | Sell |
3
-1
| -25% | – | ﹤0.01% | 1914 |
|
2018
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 1984 |
|
2018
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 2000 |
|
2018
Q2 | $1K | Hold |
4
| – | – | ﹤0.01% | 1283 |
|
2018
Q1 | $1K | Buy |
+4
| New | +$1K | ﹤0.01% | 1248 |
|
2017
Q4 | – | Hold |
0
| – | – | – | 1867 |
|
2017
Q3 | – | Hold |
0
| – | – | – | 1811 |
|
2017
Q2 | – | Hold |
0
| – | – | – | 1793 |
|
2017
Q1 | – | Sell |
-2
| Closed | -$6K | – | 1764 |
|
2016
Q4 | $6K | Buy |
+2
| New | +$6K | ﹤0.01% | 1129 |
|